These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
316 related items for PubMed ID: 2924396
1. Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643. Conway JG, Tomaszewski KE, Olson MJ, Cattley RC, Marsman DS, Popp JA. Carcinogenesis; 1989 Mar; 10(3):513-9. PubMed ID: 2924396 [Abstract] [Full Text] [Related]
2. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. Marsman DS, Cattley RC, Conway JG, Popp JA. Cancer Res; 1988 Dec 01; 48(23):6739-44. PubMed ID: 3180084 [Abstract] [Full Text] [Related]
3. Characteristics of the hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome proliferator, in male F-344 rats. Hayashi F, Tamura H, Yamada J, Kasai H, Suga T. Carcinogenesis; 1994 Oct 01; 15(10):2215-9. PubMed ID: 7955056 [Abstract] [Full Text] [Related]
4. Association of persistent peroxisome proliferation and oxidative injury with hepatocarcinogenicity in female F-344 rats fed di(2-ethylhexyl)phthalate for 2 years. Cattley RC, Conway JG, Popp JA. Cancer Lett; 1987 Dec 01; 38(1-2):15-22. PubMed ID: 3690505 [Abstract] [Full Text] [Related]
5. Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid. Marsman DS, Goldsworthy TL, Popp JA. Carcinogenesis; 1992 Jun 01; 13(6):1011-7. PubMed ID: 1600604 [Abstract] [Full Text] [Related]
6. Absence of gamma-glutamyl transpeptidase activity in neoplastic lesions induced in the liver of male F-344 rats by di-(2-ethylhexyl)phthalate, a peroxisome proliferator. Rao MS, Usuda N, Subbarao V, Reddy JK. Carcinogenesis; 1987 Sep 01; 8(9):1347-50. PubMed ID: 2887302 [Abstract] [Full Text] [Related]
7. In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators. Tomaszewski KE, Agarwal DK, Melnick RL. Carcinogenesis; 1986 Nov 01; 7(11):1871-6. PubMed ID: 3769136 [Abstract] [Full Text] [Related]
8. Long-term effects of peroxisome proliferators on the balance between hydrogen peroxide-generating and scavenging capacities in the liver of Fischer-344 rats. Tamura H, Iida T, Watanabe T, Suga T. Toxicology; 1990 Aug 01; 63(2):199-213. PubMed ID: 2399535 [Abstract] [Full Text] [Related]
9. Di-n-octyl phthalate (DOP), a relatively ineffective peroxisome inducing straight chain isomer of the environmental contaminant di(2-ethylhexyl)phthalate (DEHP), enhances the development of putative preneoplastic lesions in rat liver. DeAngelo AB, Garrett CT, Manolukas LA, Yario T. Toxicology; 1986 Nov 01; 41(3):279-88. PubMed ID: 2877511 [Abstract] [Full Text] [Related]
10. Specific changes in the protein composition of rat liver in response to the peroxisome proliferators ciprofibrate, Wy-14,643 and di-(2-ethylhexyl)phthalate. Watanabe T, Lalwani ND, Reddy JK. Biochem J; 1985 May 01; 227(3):767-75. PubMed ID: 4004798 [Abstract] [Full Text] [Related]
11. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver. Cattley RC, Popp JA. Cancer Res; 1989 Jun 15; 49(12):3246-51. PubMed ID: 2566380 [Abstract] [Full Text] [Related]
12. Ability of peroxisome proliferators to induce cell transformation, chromosome aberrations and peroxisome proliferation in cultured Syrian hamster embryo cells. Tsutsui T, Watanabe E, Barrett JC. Carcinogenesis; 1993 Apr 15; 14(4):611-8. PubMed ID: 8472324 [Abstract] [Full Text] [Related]
13. Long-term effects of hypolipidemic peroxisome proliferator administration on hepatic hydrogen peroxide metabolism in rats. Tamura H, Iida T, Watanabe T, Suga T. Carcinogenesis; 1990 Mar 15; 11(3):445-50. PubMed ID: 2311188 [Abstract] [Full Text] [Related]
14. Lack of hepatic promotional activity by the peroxisomal proliferating hepatocarcinogen di(2-ethylhexyl)phthalate. Popp JA, Garvey LK, Hamm TE, Swenberg JA. Carcinogenesis; 1985 Jan 15; 6(1):141-4. PubMed ID: 2857115 [Abstract] [Full Text] [Related]
15. Comparative studies on di-(2-ethylhexyl) phthalate-induced hepatic peroxisome proliferation in the rat and hamster. Lake BG, Gray TJ, Foster JR, Stubberfield CR, Gangolli SD. Toxicol Appl Pharmacol; 1984 Jan 15; 72(1):46-60. PubMed ID: 6710484 [Abstract] [Full Text] [Related]
16. Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet. Lalwani ND, Reddy MK, Qureshi SA, Reddy JK. Carcinogenesis; 1981 Jan 15; 2(7):645-50. PubMed ID: 7273344 [Abstract] [Full Text] [Related]
17. Studies by the National Toxicology Program on di(2-ethylhexyl)phthalate. Melnick RL, Morrissey RE, Tomaszewski KE. Toxicol Ind Health; 1987 Jun 15; 3(2):99-118. PubMed ID: 3617073 [Abstract] [Full Text] [Related]
18. In vivo studies on the mechanism of di(2-ethylhexyl)phthalate carcinogenesis. Popp JA, Garvey LK, Cattley RC. Toxicol Ind Health; 1987 Jun 15; 3(2):151-63. PubMed ID: 3303447 [Abstract] [Full Text] [Related]
19. Enhancement by peroxisome proliferators of the susceptibility to DNA damage in the liver of male F344 rats. Hayashi F, Tamura H, Watanabe T, Suga T. Cancer Lett; 1995 May 25; 92(1):87-90. PubMed ID: 7757964 [Abstract] [Full Text] [Related]
20. Suppression of choline-deficient diet-induced hepatocyte membrane lipid peroxidation in rats by the peroxisome proliferators 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio(N-beta-hydroxyethyl)- acetamide and di(2-ethylhexyl)phthalate. Perera MI, Katyal SL, Shinozuka H. Cancer Res; 1986 Jul 25; 46(7):3304-8. PubMed ID: 3708564 [Abstract] [Full Text] [Related] Page: [Next] [New Search]